Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Is the P/S ratio high or low?

The P/S ratio of 2.05 is 18% above its 5-year average of 1.74, near the high end of its 5-year range (1.37–2.18).

As of Friday, June 26, 2026. 5.90% above its 12-month average of 1.94.

DGX PS Ratio

DGX PS Ratio Chart

2.05
+3.02% 1Y
DGX PS Ratio

DGX Average PS Ratio Chart

DGX PS Ratio

DGX Current vs Average PS Ratio Chart

DGX PS Ratio Metrics

PS RATIO

2.05

PS RATIO AVG TTM

1.94

PS RATIO AVG 3Y

1.81

PS RATIO AVG 5Y

1.74

PS RATIO AVG 10Y

1.79

PS RATIO AVG 15Y

1.61

PS RATIO AVG 20Y

1.57

CURRENT VS TTM AVG

+5.90%

CURRENT VS 3Y AVG

+13.35%

CURRENT VS 5Y AVG

+18.14%

CURRENT VS 10Y AVG

+14.80%

CURRENT VS 15Y AVG

+27.09%

CURRENT VS 20Y AVG

+30.25%

DGX Competitors' PS Ratio

NAMEMARKET CAPPS RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$23.08B2.051.941.811.74
BioNTech SE (BNTX)vs ›$22.76B6.937.496.815.36
United Therapeutics Corporation (UTHR)vs ›$23.07B8.097.036.096.02
Labcorp Holdings Inc. (LH)vs ›$22.08B1.561.631.541.47
Incyte Corporation (INCY)vs ›$21.48B4.153.853.644.31
Waters Corporation (WAT)vs ›$24.57B8.216.646.616.82
STERIS plc (STE)vs ›$20.52B3.494.134.324.54
Mettler-Toledo International Inc. (MTD)vs ›$25.24B6.176.786.967.64
Veeva Systems Inc. (VEEV)vs ›$25.68B7.9112.7213.6715.98
Moderna, Inc. (MRNA)vs ›$26.45B10.616.375.296.89

P/S vs. its own history

At 2.05, P/S is richer than usual, sitting higher than 96% of its 20-year history.

20-year low

0.99

median

1.57

20-year high

2.35

cheaperricher

Sales Valuation

P/S Ratio

2.05

Market Cap / Annual Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Quest Diagnostics Incorporated (DGX)?
The P/S ratio for DGX stock is 2.05.
Is Quest Diagnostics Incorporated's P/S ratio high or low?
The P/S ratio of 2.05 is 18% above its 5-year average of 1.74, near the high end of its 5-year range (1.37–2.18).
What is the TTM average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average P/S ratio for DGX stock is 1.94.
What is the 3Y average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average P/S ratio for DGX stock is 1.81.
What is the 5Y average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average P/S ratio for DGX stock is 1.74.
What is the 10Y average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average P/S ratio for DGX stock is 1.79.
What is the 15Y average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average P/S ratio for DGX stock is 1.61.
What is the 20Y average P/S ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average P/S ratio for DGX stock is 1.57.

DGX PS Ratio History

DATEPS RATIO
2026-06-252.05
2026-06-242.02
2026-06-231.96
2026-06-221.92
2026-06-181.94
2026-06-171.96
2026-06-162.00
2026-06-152.01
2026-06-122.02
2026-06-112.02
2026-06-102.02
2026-06-092.03
2026-06-081.96
2026-06-051.99
2026-06-041.95
2026-06-031.92
2026-06-021.92
2026-06-011.91
2026-05-291.94
2026-05-281.95
2026-05-271.93
2026-05-261.92
2026-05-221.94
2026-05-211.92
2026-05-201.92
2026-05-191.89
2026-05-181.89
2026-05-151.85
2026-05-141.87
2026-05-131.90
2026-05-121.89
2026-05-111.88
2026-05-081.86
2026-05-071.90
2026-05-061.88
2026-05-051.90
2026-05-041.90
2026-05-011.91
2026-04-301.93
2026-04-291.88
2026-04-281.94
2026-04-271.95
2026-04-241.95
2026-04-231.98
2026-04-222.03
2026-04-212.08
2026-04-201.99
2026-04-171.98
2026-04-161.94
2026-04-151.94
2026-04-141.97
2026-04-131.96
2026-04-101.94
2026-04-092.01
2026-04-082.02
2026-04-072.00
2026-04-062.02
2026-04-022.01
2026-04-012.01
2026-03-311.99
2026-03-302.00
2026-03-271.98
2026-03-262.01
2026-03-251.99
2026-03-241.99
2026-03-231.99
2026-03-201.98
2026-03-191.97
2026-03-181.98
2026-03-172.02
2026-03-162.02
2026-03-132.03
2026-03-122.04
2026-03-112.04
2026-03-102.04
2026-03-092.05
2026-03-062.02
2026-03-052.07
2026-03-042.12
2026-03-032.11
2026-03-022.13
2026-02-272.15
2026-02-262.14
2026-02-252.16
2026-02-242.18
2026-02-232.16
2026-02-202.11
2026-02-192.11
2026-02-182.13
2026-02-172.14
2026-02-132.15
2026-02-122.15
2026-02-112.18
2026-02-102.14
2026-02-091.99
2026-02-061.99
2026-02-052.00
2026-02-041.97
2026-02-031.93
2026-02-021.93
2026-01-301.95
2026-01-291.90
2026-01-281.90
2026-01-271.92
2026-01-261.90
2026-01-231.89
2026-01-221.90
2026-01-211.92
2026-01-201.97
2026-01-161.97
2026-01-151.98
2026-01-141.95
2026-01-131.87
2026-01-121.83
2026-01-091.82
2026-01-081.85
2026-01-071.86
2026-01-061.88
2026-01-051.81
2026-01-021.81
2025-12-311.81
2025-12-301.83
2025-12-291.83
2025-12-261.83
2025-12-241.83
2025-12-231.82
2025-12-221.84
2025-12-191.83
2025-12-181.83
2025-12-171.87
2025-12-161.86
2025-12-151.92
2025-12-121.90
2025-12-111.89
2025-12-101.87
2025-12-091.87
2025-12-081.89
2025-12-051.90
2025-12-041.92
2025-12-031.90
2025-12-021.90
2025-12-011.91
2025-11-281.97
2025-11-261.98
2025-11-252.00
2025-11-241.98
2025-11-211.99
2025-11-201.95
2025-11-191.94
2025-11-181.93
2025-11-171.94
2025-11-141.95
2025-11-131.95
2025-11-121.95
2025-11-111.97
2025-11-101.92
2025-11-071.87
2025-11-061.84
2025-11-051.86
2025-11-041.85
2025-11-031.86
2025-10-311.83
2025-10-301.83
2025-10-291.82
2025-10-281.86
2025-10-271.88
2025-10-241.90
2025-10-231.91
2025-10-221.89
2025-10-211.92
2025-10-202.04
2025-10-172.04
2025-10-162.01
2025-10-152.01
2025-10-141.99
2025-10-131.96
2025-10-101.98
2025-10-091.95
2025-10-081.94
2025-10-071.95
2025-10-061.92
2025-10-031.93
2025-10-021.94
2025-10-011.96
2025-09-302.05
2025-09-292.03
2025-09-262.03
2025-09-251.99
2025-09-242.01
2025-09-232.01
2025-09-221.98
2025-09-191.97
2025-09-181.97
2025-09-171.96
2025-09-161.93
2025-09-151.94
2025-09-121.96
2025-09-111.97
2025-09-101.93
2025-09-091.96
2025-09-081.96
2025-09-051.97
2025-09-041.93
2025-09-031.93
2025-09-021.92
2025-08-291.95
2025-08-281.92
2025-08-271.93
2025-08-261.94
2025-08-251.92
2025-08-221.94
2025-08-211.97
2025-08-201.98
2025-08-191.96
2025-08-181.92
2025-08-151.93
2025-08-141.92
2025-08-131.92
2025-08-121.92
2025-08-111.92
2025-08-081.90
2025-08-071.87
2025-08-061.86
2025-08-051.86
2025-08-041.85
2025-08-011.83
2025-07-311.80
2025-07-301.81
2025-07-291.80
2025-07-281.80
2025-07-251.81
2025-07-241.85
2025-07-231.83
2025-07-221.98
2025-07-211.85
2025-07-181.86
2025-07-171.87
2025-07-161.86
2025-07-151.85
2025-07-141.87
2025-07-111.87
2025-07-101.91
2025-07-091.93
2025-07-081.92
2025-07-071.94
2025-07-031.97
2025-07-021.96
2025-07-011.99
2025-06-302.00
2025-06-271.98
2025-06-261.97
2025-06-251.99
2025-06-242.00
2025-06-232.00
2025-06-202.00
2025-06-182.00
2025-06-171.99
2025-06-162.03
2025-06-132.00
2025-06-121.99

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis